Table 3.
Distribution of illness acceptance levels according to AIS, stigmatization levels measured with 6-item Stigmatization Scale and 33-item Feelings of Stigmatization Questionnaire, and quality of life scores determined with DLQI
| Scale | Statistical variable | Sociodemographic variable | Total | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sex | Age (years) | Place of residence | Duration of disease (years) | |||||||||||
| Women | Men | 18–30 | 31–40 | 41–50 | 51–60 | > 60 | Village | Town/city | Up to 5 | 6–19 | 20 and more | |||
| N | 189 | 177 | 63 | 96 | 66 | 87 | 54 | 93 | 273 | 114 | 144 | 108 | 366 | |
| AIS | (±SD) | 22.56 (±6.93) | 25.58 (±7.94) | 25.24 (±6.48) | 24.16 (±8.14) | 21.73 (±7.30) | 23.41 (±7.79) | 26.11 (±7.51) | 25.10 (±7.66) | 23.65 (±7.53) | 24.55 (±7.36) | 23.44 (±7.40) | 24.22 (±8.12) | 24.02 (±7.56) |
| Me | 23 | 27 | 25 | 24 | 20.5 | 23 | 25 | 28 | 23 | 24 | 23 | 24 | 24 | |
| Min. | 11 | 10 | 13 | 13 | 11 | 11 | 10 | 13 | 10 | 13 | 11 | 10 | 10 | |
| Max. | 40 | 40 | 36 | 40 | 37 | 37 | 40 | 39 | 40 | 40 | 37 | 40 | 40 | |
| p-Value | < 0.001* | 0.0098* | 0.102 | 0.4613 | – | |||||||||
| Post hoc | – |
18–30 versus 41–50: 0.047* 41–50 versus > 60: 0.013* |
– | – | – | |||||||||
| 6-item Stigmatization Scale | (±SD) | 8.71 (±4.14) | 8.75 (±3.92) | 6.95 (±4.33) | 9.25 (±4.34) | 10.14 (±3.03) | 9.03 (±3.89) | 7.67 (±3.74) | 8.42 (±4.21) | 8.84 (±3.97) | 8.66 (±4.53) | 9.21 (±4.17) | 8.17 (±3.18) | 8.73 (±4.02) |
| Me | 9 | 9 | 6 | 9 | 10 | 9 | 7.5 | 8 | 9 | 9 | 9 | 8.5 | 9 | |
| Min. | 0 | 0 | 0 | 1 | 4 | 1 | 0 | 1 | 0 | 0 | 0 | 1 | 0 | |
| Max. | 18 | 17 | 18 | 16 | 15 | 17 | 13 | 17 | 18 | 18 | 17 | 14 | 18 | |
| p-Value | 0.936 | < 0.001* | 0.349 | 0.257 | – | |||||||||
| Post hoc | – |
18–30 versus 31–40: 0.002* 18–30 versus 41–50: < 0.001* 18–30 versus 51–60: 0.011* 41–50 versus > 60: 0.028* |
– | – | – | |||||||||
| 33-item Feelings of Stigmatization Questionnaire | (±SD) | 91.67 (±24.04) | 88.34 (±18.44) | 87.24 (±19.59) | 89.06 (±22.84) | 102.59 (±18.82) | 89.31 (±23.05) | 81.00 (±15.08) | 95.35 (±21.15) | 88.25 (±1.43) | 90.45 (±22.63) | 92.85 (±20.44) | 83.50 (±21.38) | 90.06 (±21.55) |
| Me | 91 | 88 | 84 | 83.5 | 105 | 86 | 85.5 | 97 | 87 | 90.5 | 92 | 83.5 | 90 | |
| Min. | 48 | 37 | 61 | 49 | 62 | 37 | 53 | 49 | 37 | 48 | 49 | 37 | 37 | |
| Max. | 130 | 126 | 124 | 130 | 130 | 130 | 115 | 130 | 130 | 130 | 130 | 130 | 130 | |
| p-Value | 0.057 | < 0.001* | 0.035* | 0.041* | – | |||||||||
| Post hoc | – |
31–40 versus 41–50: 0.003* 41–50 versus 51–60: 0.028* 41–50 versus > 60: < 0.001* |
– | NS | – | |||||||||
| DLQI | (±SD) | 16.81 (±6.08) | 18.88 (±5.54) | 16.49 (±6.25) | 17.33 (±6.20) | 17.95 (±6.00) | 19.79 (±4.96) | 16.83 (±5.63) | 16.18 (±7.25) | 18.37 (±5.27) | 17.06 (±5.46) | 17.99 (±5.37) | 18.36 (±6.97) | 17.81 (±5.91) |
| Me | 17 | 19 | 16 | 18 | 17.5 | 21 | 18 | 16 | 19 | 18 | 18 | 20.5 | 18 | |
| Min. | 0 | 0 | 3 | 0 | 0 | 6 | 5 | 0 | 0 | 3 | 5 | 0 | 0 | |
| Max. | 30 | 29 | 29 | 30 | 29 | 30 | 23 | 30 | 30 | 30 | 30 | 29 | 30 | |
| p-Value | < 0.001* | 0.003* | 0.004* | 0.021* | – | |||||||||
| Post hoc | – |
18–30 vs. 51–60: 0.004* 31–40 versus 51–60: 0.020* |
– | Up to 5 versus 20 and more: 0.025* | – | |||||||||
AIS Acceptance of Illness Scale, DLQI Dermatology Life Quality Index, Max. maximum, Me median, Min. minimum, NS not significant, SD standard deviation, mean
*Statistically significant difference